Editorial: The interaction of NKG2D and its ligands in health and diseases

Front Immunol. 2022 Dec 8:13:1099580. doi: 10.3389/fimmu.2022.1099580. eCollection 2022.

Silvana Gaudieri^{1

2

3}, Hugh T Reyburn⁴, Mar Vales-Gomez⁴, Chanvit Leelayuwat⁵

¹ School of Human Sciences, University of Western Australia, Crawley, WA, Australia.
² Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.
³ Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
⁴ National Center for Biotechnology, Spanish National Research Council, Madrid, Spain.
⁵ Department of Clinical Immunology and Transfusion Sciences and The Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.

No abstract available

Keywords: MIC - major histocompatibility complex (MHC) class I-related chain; NK cells; NKG2D; ULBP - UL16 binding protein; disease.

Publication types